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Effect of type 2 diabetes on the dynamic 
response characteristics of leg vascular 
conductance during exercise
Oscar MacAnaney1, Heather Reilly1, Donal O’Shea2,
Mikel Egaña1 and Simon Green3
Abstract
In this study we tested the hypothesis that type 2 diabetes impairs the dynamic response of leg vascular conductance (LVC) 
during exercise. LVC (leg blood flow/mean arterial pressure) responses were studied during intermittent contractions 
of the calf muscle in subjects with type 2 diabetes (n = 9), heavy controls (n = 10) and lean controls (n = 8) using a 
biexponential function and an estimate of the mean response time (MRT). The time constant of the second phase of LVC 
was significantly greater in type 2 diabetes (66.4 ± 29.2 s) than the heavy (22.2 ± 13.4 s) and lean (21.8 ± 9.3 s) controls, 
resulting in a significantly greater MRT in the diabetic group (median [IQR] = 30.7 [24.6–46.5] s versus 16.3 [4.3–23.2] 
s and 18.4 [13.7–19.3] s). These data support the hypothesis and suggest that a slowed hyperaemic response in the 
exercising limb might contribute to exercise intolerance in diabetic subjects.
Keywords
Control, diabetes mellitus, exercise, hyperaemia, muscle
characteristics14 of muscle blood flow are altered in type 2 
diabetes.
Systems control principles and assessment of dynamic 
response characteristics have been used to explore the con-
trol of ventilation and V˙o
2
 during exercise for at least three 
decades,14-16 but their application to the study of the control 
of blood flow in human skeletal muscle is much more lim-
ited.13, 17 We have adapted venous occlusion plethysmogra-
phy to the assessment of dynamic response characteristics 
of leg blood flow in the contracting calf,18 an important 
model of exercise in the study of peripheral vascular dis-
ease.19 Since this hyperaemic response is linked closely to 
the control of vasodilation and, thus vascular conductance 
in contracting skeletal muscle, we used this approach to test 
the hypothesis that type 2 diabetes impairs the dynamic 
response of leg vascular conductance during exercise.
Introduction
Exercise intolerance is a major complication of type 2 dia-
betes1-4 that is associated with increased mortality.5 Although 
the aetiology of exercise intolerance in type 2 diabetes is not 
well understood, both a reduction in peak O
2
 uptake (V˙o
2
)1-4 
and a profound slowing of the dynamic response of V˙o
2
 dur-
ing submaximal exercise3, 6 have been observed in patients 
with type 2 diabetes. These data are consistent with the 
exaggerated fall in muscle PCr and pH during calf exercise 
in type 2 diabetes,7 suggesting that mechanisms underlying 
the control of V˙o
2
 are impaired in this disease.
The control of the dynamic response of V˙o
2
 during exer-
cise is considered important to the process of fatigue and 
tolerance of exercise.8 The control of V˙o
2
 depends, to some 
extent, on the control of O
2
 delivery and muscle blood 
flow.9,10 Recent evidence of a lower muscle blood flow
during steady-state, submaximal exercise2, 11 raises the pos-
sibility that the dynamic control of muscle blood flow is 
impaired in type 2 diabetes. This would help explain both 
the larger rise in the NIRS-derived deoxygenated haemo-
globin in contracting muscle observed in type 2 diabetes6 
and the faster decline in ‘microvascular PO
2
’ during twitch 
contractions in the streptozotocin-induced diabetic rat.12 
However, steady-state measures of limb blood flow shed 
little light on the dynamic response prior to these measure-
ments,13 and it is not known if the dynamic response 
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Methods
Subjects
Nine women with type 2 diabetes, 10 overweight but other-
wise healthy women (‘heavy controls’) and 8 lean and 
healthy women (‘lean controls’) volunteered to participate 
in this study. Healthy subjects were recruited from Trinity 
College Dublin and diabetic subjects were recruited from 
the Diabetes Unit at St Colmcilles Hospital, Dublin. 
Exclusion criteria for participation in this study included 
(1) a diagnosis of peripheral arterial disease (ankle:brachial 
pressure index < 0.9), hypertension (systolic blood pressure 
> 140 mmHg), coronary heart disease (described in the 
following), neuropathy or retinopathy, (2) were smokers or 
had smoked during the 12-month period preceding the 
study or (3) were taking insulin, beta-blockers, calcium 
channel blockers or any other antihypertensive drugs. All 
diabetic subjects had a clinical history of diabetes that 
ranged between 1 and 4 years; but immediately prior to the 
study did not have clinical evidence of ischaemic heart dis-
ease (normal ECG during treadmill stress test) or renal and 
hepatic dysfunction (urinary protein < 200 mg dl–1; urinary 
creatinine levels < 2.2 mg dl–1).
Physical characteristics of the subjects are shown in 
Table 1. Prior to and during this study the diabetic subjects 
were taking either metformin (n = 5), avandmen (n = 1), 
statins (n = 3) and/or an angiotensin-converting enzyme 
(ACE) inhibitor (n = 1). None of the subjects were taking 
contraceptive drugs during this period. Subjects were both 
premenopausal (n = 11: 4 diabetic, 4 heavy and 3 lean) and 
postmenopausal (n = 16: 5 diabetic, 6 overweight and
5 lean) whose ages ranged between 34 and 69 years. All 
premenopausal subjects were tested during days 7–10 of 
their menstrual cycle. Subjects were classified as sedentary 
(≤1 hour week–1 of moderate intensity exercise in the pre-
ceding 3 months), which was confirmed using the Low 
Level Physical Activity Recall (LOPAR) questionnaire.20,21 
All subjects provided informed consent prior to their par-
ticipation in this study, and the study was approved by the 
institutional ethics committee and conducted in accordance 
with the Declaration of Helsinki (2008).
Experimental overview
Subjects were tested on 2 days. On the first day they were 
familiarised with calf exercise and the protocol to be com-
pleted on the second day, and then they completed a series of 
maximum efforts for the determination of maximum volun-
tary force (MVC). On the second day they performed three 
bouts of high-intensity calf exercise during which leg blood 
flow, mean arterial pressure and leg vascular conductance 
were recorded. All tests were conducted at the same time of 
the day (i.e. mid morning) and same ambient temperature 
(i.e. 21°C). Subjects did not consume alcohol and caffeine 
during a 24-hour period, or perform intense exercise for a 
48 hour period, immediately before the testing sessions.
Calf exercise
Single-leg calf exercise was performed in an inclined posi-
tion (67o) on a custom-built ergometer described previously 
by us.18 For both the determination of MVC and the repeated 
bouts of calf exercise, subjects were tilted rapidly from the 
supine position and then initiated contractions within ~5 s 
of reaching the inclined position. The calf MVC was deter-
mined as the highest force during a series of five maximal 
contractions, each separated by 60 s of rest in the supine 
position. Then, on a following day, the subject rested for 
20 min in the supine position during which resting cardio-
vascular measurements were made (see the ‘Leg vascular 
conductance’ section), before being tilted upright to the 
inclined position and commencing calf exercise soon 
after.18 Calf exercise consisted of intermittent and static 
contractions of the calf muscle (6 s duty cycle: 2 s contrac-
tion, 4 s relaxation) at a target force of 70% MVC. Each 
subject performed three calf exercise trials, separated by 
20–30 min of rest in the supine position, and the duration of 
each exercise trial was 6 minutes.
Leg vascular conductance
Estimates of leg vascular conductance (LVC) during rest 
and calf exercise were based on simultaneous measurements 
Table 1. Physical characteristics, fasting blood-borne measurements and calf strength (MVC) in the three groups of subjects. Median 
and interquartile ranges are presented for weight and body mass index (BMI).
Age (years) Height (cm) Weight (kg) BMI (kg.m-2) Glucose
(mmol/L)
Insulin
(mmol/L)
HBA1c (%) MVC (N)
Type 2 
Diabetes
49.1 ± 5.7 165 ± 7 85.5*
(74.5–117.9)
32.5*
(27.9–38.8)
8.1 ± 1.7*† 12.3 ± 4.8* 6.8 ± 1.0*† 764 ± 194
Heavy 
Controls
52.7 ± 14.7 159 ± 4* 72.7
(69.1–86.1)
29.3
(29.0–31.0)*
4.4 ± 0.9 11.3 ± 4.4* 5.7 ± 0.5 701 ± 194
Lean Controls 53.1 ± 12.4 172 ± 7 64.9
(63.0–71.0)
22.6
(22.0–24.0)
4.5 ± 0.4 7.6 ± 1.3 5.6 ± 0.2 766 ± 273
* Significantly different (p < 0.05) from the lean group.
† Significantly different (p < 0.05) from the heavy control group.
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of leg blood flow and mean arterial pressure (LVC = leg 
blood flow/mean arterial pressure). Resting measurements 
of leg blood flow and mean arterial pressure (MAP) were 
made in the final three minutes of the initial 20 min rest 
period and while the subject was in the supine position. In 
contrast, exercise measurements of leg blood flow and MAP 
were made in the inclined position (67o), a position that was 
felt to better represent the haemodynamic conditions under 
which these muscles work during daily activities (e.g. walk-
ing) than the supine position. Although it would have been 
preferable to make both resting and exercise measurements 
in the inclined position, it is difficult to obtain stable esti-
mates of leg blood flow soon after tilting to the upright 
position, as leg blood flow increases rapidly during tilting 
and can take several minutes to stabilise when in the tilted 
position.18 Moreover, our pilot studies18 showed that resting 
on the ergometer in the inclined position for several minutes 
often caused profound leg swelling and discomfort.
During calf exercise, leg blood flow, MAP and, thus, LVC 
were measured during each period of relaxation between 
contractions.18 For each of the three exercise trials this 
yielded 60 measurements of these three variables. Leg blood 
flow was measured during calf exercise using venous occlu-
sion strain-gauge plethysmography,18 a technique which pro-
vides similar estimates of limb blood flow during exercise 
when compared with Doppler ultrasound.22 Briefly, a thigh 
cuff was inflated before exercise and maintained throughout 
exercise at a pressure of 55 mmHg. Leg blood flow was then 
assessed during the 4-s relaxation periods between contrac-
tions by measuring the change in leg volume (Figure 1) 
using a mercury-in-Silastic strain gauge, placed around the 
widest girth of the calf, and a plethysmograph (Hokanson 
EC-6, Washington, USA). The plethysmographic estimates 
of leg blood flow, normally expressed relative to the resting 
limb volume (ml 100 ml–1 min–1), were converted to milli-
litres per minute using an estimate of each subject’s leg 
volume obtained from anthropometric measurements of the 
leg.23 These blood flow estimates were then normalised to 
the mean force (N) produced immediately before its mea-
surement (ml–1 min–1 N–1). MAP was measured beat by beat 
at rest and during exercise using applanation tonometry of 
the radial artery (COLIN CBM7000, Japan). There were no 
significant differences between these tonometric MAP val-
ues and those obtained on the contralateral arm every 2 min-
utes using an oscillometric method (Omron M7). LVC 
during exercise was calculated by dividing leg blood flow by 
the simultaneous measurement of MAP plus the estimated 
hydrostatic pressure acting at the midpoint of the calf in this 
inclined position.18, 24
Dynamic response characteristics of LVC
LVC responses (scaled to force) from the three exercise tri-
als were averaged to yield a temporal profile of LVC based 
on 60 averaged estimates for each subject (an example is 
shown later in Figure 4). Of the 27 individual responses, 22 
of them exhibited a clear biphasic pattern and the remain-
ing five responses more closely resembled a monophasic 
(two heavy control subjects) or triphasic pattern (one lean 
control, one heavy control, one diabetic subject). On this 
basis, the LVC responses of all subjects were fitted using a 
biphasic function and the impact that deviations in mea-
sured responses from this biphasic response (in the case of 
five subjects) has on interpretation of the data is dealt with 
in the Discussion. The biphasic response was represented 
by the biexponential function
 LVC (t) = a + A1(1 – e–(t – TD1)/t1))U1 + A2(1 – e–(t – TD2)/t2))U2
where a represents LVC at t = 0, and the amplitude, time 
delay and time constant of the first and second phases are 
represented by A1–A2, TD1–TD2 and t1–t2, respectively. 
The parameters U1 and U2 are conditional expressions that 
limit the fitting of a particular phase to the period at and 
beyond the time delay associated with that phase. Data that 
exceeded the 95% prediction intervals during an initial fit 
of a model were excluded, and no more than four data 
points were removed from the original time series of 
data. The models were fitted to the data using a weighted 
least-squares nonlinear regression procedure (LevMarqdt, 
TableCurve 2D, Jandel Scientific).
A graphic illustration of this biphasic model is shown in 
Figure 2. The magnitude of the first phase of the LVC 
response is defined by the parameter A1, and the temporal 
response of this phase is defined with respect to its onset 
relative to the start of exercise (i.e. the time delay TD1) and 
Figure 1. A recording of force and the plethysmogram
(‘calf girth (V)’) during calf exercise that illustrates the pulsatile 
increases in the calf girth (and volume) between contractions. 
The voltage change between two contractions is shown 
between the dashed vertical lines, and this voltage change is 
converted to a volume change relative to the resting limb 
volume (in ml 100 ml–1) using an electronic calibration internal 
to the plethysmograph. Leg blood flow is then calculated from 
this volume change and the period over which it occurs 
(see Methods for further explanation).
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its rate of increase towards its asymptotic value (t1). This 
first phase is rapidly responding (small TD and t) and usu-
ally complete within ~10 s. The magnitude of the second 
phase is defined by parameter A2, its onset is delayed rela-
tive to the onset of the first phase (i.e. TD2) at ~20–30 s 
after exercise onset, and its rate of rise towards its asymp-
totic value (t2) is generally slower than that of the first 
phase. The impact that the combined effect that both phases 
has on the size and speed of the overall LVC response 
for each subject can be represented by an ‘end-exercise’ 
response (i.e. LVC at t = 360 s) and a mean response time 
(MRT) calculated using the fitted biphasic function. The 
MRT, which represents the time to reach ~63% of the over-
all amplitude of the response from the baseline value, was 
calculated as a weighted sum of the time delay and time 
constant of each phase:
 MRT = [A1/(A1 + A2).(TD1 + t1)] +
 [A2/(A1 + A2).(TD2 + t2)]
Heart rate
Heart rate was measured from the R–R interval of single-
lead (lead II) ECG at rest and every 5 s during each of the 
three calf exercise trials and averaged to yield a single time 
series of heart rate data for each subject. The dynamic 
response of heart rate during calf exercise was fitted using 
a monoexponential function:
 Heart rate (t) = a + A(1 – e–(t – TD)/t)
where a is the baseline heart rate, A is the amplitude of the 
exercise response, TD is the delay in rise of heart rate after 
exercise onset and t is the time constant of the response. 
The fitting procedures were identical to that described for 
LVC, and because the dynamic structure of the heart rate 
response was not as consistent between subjects as the LVC 
response, a relatively simpler, monophasic function was 
chosen.
Statistics
Cardiovascular data at rest and during exercise were com-
pared between the three groups of subjects using a one-
way analysis of variance (ANOVA) and differences were 
located using Tukey’s post hoc test (SigmaStat 3.5, Systat, 
USA). Data that were not normally distributed were anal-
ysed using a Kruskal–Wallis test and multiple compari-
sons were then performed using Dunn’s method. The level 
of significance was set at p ≤ 0.05. Results are shown as 
either mean ± SD for data that were normally distributed 
or as median and interquartile ranges for data that were not 
normally distributed.
Results
Calf exercise
There were no significant differences in MVC between the 
three groups (Table 1). The submaximal force sustained 
during calf exercise and averaged across all contractions 
was not significantly different between subjects with type 2 
diabetes (66% ± 4% MVC), heavy controls (70% ± 3% 
MVC) and lean controls (67% ± 5% MVC).
Haemodynamic measurements
Plethysmographic measurements of resting blood flow 
were not different between the diabetic (1.78 ± 0.40 ml 100 
ml–1 min–1), heavy control (1.56 ± 0.57 ml 100 ml–1 min–1) 
and lean control (1.69 ± 0.63 ml 100 ml–1 min–1) groups. 
Leg blood flow was converted to units of ml min–1 using 
anthropometric estimates of leg volume and then used to 
measure leg blood flow and LVC at rest and during exer-
cise, as reported in Table 2 and Figure 3. There were no 
significant differences in leg blood flow, MAP or LVC 
measurements at rest, at 20 s into exercise or at the end of 
exercise between the three groups (Table 2). Although calf 
exercise evoked a significant increase in MAP in all three 
groups, this effect was small (~5–6 mmHg) and not differ-
ent between the groups. The group-averaged responses of 
leg blood flow, MAP and LVC during calf exercise are 
shown in Figure 3. Representative LVC responses scaled to 
force, as well as responses predicted from the fitting of the 
biphasic function, are shown in Figure 4. Parameter esti-
mates defining the biphasic response of LVC, as well as the 
MRT and end-exercise values calculated using these param-
eter estimates, are shown in Table 3. The goodness of fit, as 
reflected in the adjusted R2 value, was similar between the 
type 2 diabetes (0.77 ± 0.11), heavy control (0.78 ± 0.18) 
and lean control (0.76 ± 0.23) groups. The MRT was
significantly larger (p < 0.05) in type 2 diabetes than the 
Figure 2. A graphic illustration of the biphasic model that was 
fitted to leg vascular conductance responses.
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control groups; whereas the end-exercise values were 
similar between the three groups. The time constant of the 
second phase (t2) was also significantly larger in type 2 
diabetes than controls. None of the remaining parameters 
were significantly different between the groups, although 
the parameter TD1 tended to be different between the 
groups (ANOVA, p = 0.06).
Heart rate
The baseline or resting heart rate (parameter a) immedi-
ately before calf exercise was not significantly different 
between the type 2 diabetes (67 ± 11 bpm), heavy control 
(67 ± 8 bpm) and lean control (61 ± 8 bpm) groups. When 
comparing the dynamic response characteristics of heart 
rate between these three groups (type 2 diabetes versus 
heavy versus lean), there were no significant differences 
in the amplitude (parameter A: 17.3 ± 4.4 versus 14.5 ±
4.7 versus 14.7 ± 8.4 bpm), time delay (parameter TD:
0.2 ± 0.6 versus 0.2 ± 0.3 versus 2.2 ± 3.5 s) or time
constant (parameter t: 6.7 ± 5.1 versus 11.8 ± 17.9 versus 
14.2 ± 16 s).
Discussion
A major finding of the present study is that, compared with 
both lean and heavy controls, the response of LVC and blood 
flow during calf exercise was profoundly slowed in type 2 
diabetes patients. In contrast, the response of MAP during 
exercise was not different between these three groups. This 
slowing of the hyperaemic response, evident in a signi-
ficantly larger MRT for LVC, can be attributed entirely to 
the slower rate of increase (i.e. larger time constant) of the 
second phase of the hyperaemic response; whereas the first 
phase was unaffected by type 2 diabetes. The similar LVC 
and blood flow responses between lean and heavy controls 
suggests that obesity per se is not responsible for the impaired 
hyperaemic response in type 2 diabetes.
Dynamic response characteristics of leg vascular 
conductance
In the presence of similar MAP responses between the three 
groups, the slower leg blood flow response in type 2 diabe-
tes can be attributed to a slower response of LVC (Figure 3) 
Table 2. Leg blood flow, mean arterial pressure and leg vascular conductance measured at rest, at 20 s of exercise (Ex20) and the 
end of 6 minutes of exercise (Exend) in type 2 diabetes, heavy controls and lean controls.
Leg Blood Flow (ml min–1)
  
Mean Arterial Pressure (mmHg)
 
Leg Vascular Conductance 
(ml min–1 mmHg–1)
Rest Ex20 Exend Rest Ex20 Exend Rest Ex20 Exend
Type 2 
Diabetes
49 ± 21 502 ± 322 742 ± 347 93.0 ± 7.0 94.3 ± 7.4 98.0 ± 8.7 0.53 ± 0.24 3.10 ± 1.90 4.5 ± 2.1
Heavy 
Controls
40 ± 14 610 ± 158 844 ± 313 91.4 ± 11.3 92.0 ± 11.9 96.8 ± 11.2 0.45 ± 0.20 4.01 ± 1.18 5.3 ± 2.0
Lean 
Controls
39 ± 15 664 ± 331 909 ± 584 93.1 ± 10.8 93.6 ± 13.1 98.0 ± 14.4 0.43 ± 0.16 4.19 ± 2.16 5.6 ± 3.6
Table 3. Dynamic response characteristics of leg vascular conductance (LVC) during calf exercise in type 2 diabetes, heavy 
controls and lean controls. Amplitudes (‘a’, ‘A1’, ‘A2’ and ‘end-exercise LVC’) are expressed in ml min–1 mmHg–1 N–1, and time-
based parameters (‘TD1’, t1, TD2, t2 and MRT) are expressed in seconds. See Methods and Figure 2 for further description. Mean 
response time (MRT) data were not normally distributed and are presented as median and interquartile range.
Baseline Phase 1 Phase 2
a A1 TD1 t1 A2 TD2 t2 MRT End-exercise 
LVC
Type 2
Diabetes
0.09 ± 0.04 0.54 ± 0.28 0.0 ± 0.0 3.4 ± 2.2 0.35 ± 0.20 27.1 ± 16.0 66.4 ± 29.2* 30.7
(24.6-46.5)*
0.96 ± 0.35
Heavy 
Controls
0.09 ± 0.03 0.65 ± 0.22 1.3 ± 1.6 3.1 ± 3.3 0.36 ± 0.20 23.2 ± 7.1 22.2 ± 13.4 16.3
(4.3-23.2)
1.04 ± 0.35
Lean Controls 0.07 ± 0.05 0.69 ± 0.26 0.5 ± 1.4 3.5 ± 2.3 0.37 ± 0.16 27.6 ± 15.1 21.8 ± 9.3 18.4
(13.7-19.3)
1.10 ± 0.37
* Significantly different (p < 0.05) from the other groups.
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and, thus, vasodilation in the contracting skeletal muscle. A 
high frequency of measurements of LVC during exercise 
combined with empirical modelling of this dynamic 
response enables the dynamic structure of these phases to 
be resolved.14 The dynamic response of each phase is 
assumed to be an exponential process defined by a set of 
parameters that include the amplitude, time constant and 
time delay. It has been suggested that each phase and the 
parameters which define its structure potentially represent a 
distinct set of underlying control mechanisms involved in 
vascular control.13 In the present study, LVC was modelled 
using a biexponential function on the basis that a biphasic 
response was more apparent (22/27 subjects) than either a 
monophasic or triphasic response. This is consistent with 
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Figure 3. Group averaged responses of leg blood flow, mean 
arterial pressure and leg vascular conductance during calf 
exercise. ‘Mean arterial pressure’ in this figure is the local 
arterial pressure estimated to act at the popliteal fossa, and so 
the abrupt increase in this response after t = 0 s represents the 
arterial pressure measured in the forearm plus the hydrostatic 
pressure that acts at the knee when the subject is rapidly tilted 
to the inclined position.
Figure 4. Leg vascular conductance (LVC) responses (open 
circles) during calf exercise in an individual with type 2 diabetes, 
a heavy control and a lean control. The continuous lines of best 
fit illustrate the biphasic response of LVC. Note the relatively 
slow response of the second hyperaemic phase in the diabetic 
subject.
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the biphasic response of arteriolar vasodilation to muscle 
stimulation observed in the hamster cremaster muscle prep-
aration,25,26 as well as the biphasic response of forearm 
blood flow during moderate handgrip exercise.17 However, 
as is apparent in forearm vascular conductance responses to 
handgrip exercise,17 not all responses can be characterised 
by the same number of phases. In the present study, two 
subjects (both heavy controls) exhibited a monophasic 
response and, thus, the estimated amplitude of the second 
phase of these responses was zero, whereas three subjects 
(one from each group) exhibited a triphasic response, and 
this would result in an overestimate of the amplitude and 
time constants of the second phase for these subjects. 
However, neither of these observations can account for the 
longer time constant of the second phase of the hyperaemic 
response in the diabetic group compared with the lean or 
heavy control groups.
Mechanisms of vascular control during exercise
A wide range of mechanisms probably contributes to the 
biphasic control of vascular conductance in contracting 
human muscles, although the precise contribution of any 
one mechanism to either phase is not yet clear. The first 
phase of vasodilation is initiated in response to the first con-
traction and is fully expressed within ~10–20 s.17 Likely 
mechanisms involved in this initial phase include K+ release 
into the interstitium27 and mechanical deformation of resis-
tance vessels,28 as well as acetylcholine release from the 
motor nerves,29 although there is some uncertainty regarding 
its effectiveness in contracting human skeletal muscle.30,31 In 
addition, the increase in the perfusion pressure under the 
permissive influence of the ‘muscle pump’32 will increase 
limb blood flow beyond that supported by vasodilation, and 
it will do so in response to the first contraction and particu-
larly when the limb is well below the level of the heart.18
The second phase of vasodilation is initiated at ~20–30 s 
after exercise onset (Table 2),17 and it has been suggested 
that the second phase is a flow-mediated, endothelium-
dependent phase13 that is perhaps linked causally to the 
decline in muscle PO
2
.25 It is likely that adenosine, a potent 
vasodilator in human skeletal muscle,33 is linked to the 
decline in muscle PO
2
 and contributes to this second 
phase,25 despite the uncertainty about its time course of 
accumulation in the interstitial fluid during the first phase 
of the hyperaemic response.34 Both nitric oxide and prosta-
glandins may be involved in this vascular action of 
adenosine or contribute independently to the exercise 
hyperaemic response,35,36 although the inhibition of nitric 
oxide synthesis has little effect on the rise in muscle blood 
flow during exercise.31, 37 Both the classic autoregulation 
(Bayliss mechanism) response and muscle sympathetic 
nerve activation have the potential to modulate both bipha-
sic responses; but their contributions to the dynamic 
response characteristics have not, to the best of the authors’ 
knowledge, been established.
Mechanisms of impaired vascular control in diabetes
The slowed hyperaemic response observed in the present 
study combined with the more rapid decline in muscle 
microvascular PO
2
 and deoxygenated haemoglobin12, 38 in 
type 2 diabetes suggests that the speed of the vasodilatory 
response to a metabolic stimulus is impaired in this disease. 
In contrast, neither the end-exercise value or phasic ampli-
tudes of LVC were significantly affected by type 2 diabetes 
(Table 2), suggesting that the capacity to vasodilate under 
exercise conditions that evoke near-maximal blood flows18 
remains intact. However, the phase 1 amplitude and end-
exercise value for LVC was 15–20% lower in the diabetic 
group and, although this difference was not significant, the 
large between-subject variation in responses might have 
obscured an important physiological difference which 
warrants further investigation. Nevertheless, given that the 
initial hyperaemic response (phase 1) was not significantly 
affected by type 2 diabetes, the slowed second phase 
response is probably not due to a lower preceding flow 
stimulus and above-mentioned mechanisms that underlie 
it and is perhaps more likely explained by the failure of 
endothelial-mediated vasodilation to amplify the early rise 
in vascular conductance.
There are a number of potential mechanisms that under-
lie vascular dysfunction in type 2 diabetes.39 Of particular 
relevance to the present findings is evidence that type 2 
diabetes or hyperglycaemia impairs flow-mediated and 
endothelial-dependent control of vascular resistance in the 
human forearm.11, 40-41 Flow-mediated and endothelial-
dependent control mechanisms are thought to be central to 
the time-dependent propagation of vasodilation from distal 
to more proximal resistance vessels, a critical process in 
controlling the hyperaemic response during muscle contrac-
tions.42 This process depends on the gap junction intercel-
lular communication between endothelial cells and smooth 
muscle,42 a process that is affected by high glucose concen-
trations.39 It is tempting to speculate that hyperglycaemia-
induced disruption of this cell-to-cell mediated control over 
the vascular response during exercise contributes to the 
slowing of the second phase of the hyperaemic response in 
type 2 diabetes.
To some extent the vascular mechanisms which impair the 
muscle hyperaemic response in type 2 diabetes might depend 
on the exercise model used and/or muscles studied. That the 
amplitudes of the LVC response during high-intensity calf 
exercise were unaffected by type 2 diabetes is consistent with 
the maximal vasodilation in the hindlimb of the streptozoto-
cin-induced diabetic rat being similar to control animals.43 
However, they contrast with the lower steady-state values of 
limb blood flow during lower intensity cycling11 and knee 
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extension exercise.2 We can only speculate on the reasons for 
this discrepancy and which might include both the intensity 
of exercise (moderate versus ‘maximal’), the muscles stud-
ied (quadriceps versus calf) and the potential influence 
of muscle atrophy (if present) on vascular conductance. In 
addition, the influence of sympathetically mediated vaso-
constriction in muscle on exercise hyperaemia in type 2 dia-
betes warrants further study, since it is increased at rest in an 
insulin-resistant state44 and has been proposed as a possible 
candidate for the age-related blunting of the hyperaemic 
response to exercise involving the quadriceps muscles.45 
The pharmacotherapy used by the present diabetic group, 
which includes metformin, statins and ACE inhibitors, is 
unlikely to account for the vascular dysfunction observed in 
the present study given that these drugs generally enhance 
vascular function.
It has been suggested that cardiac dysfunction, a major 
complication of type 2 diabetes,7 might contribute to altered 
blood flow or V˙o
2
 responses in type 2 diabetes.1-4 This, how-
ever, seems an unlikely mechanism in the present study 
given the following: (1) LVC reflects vasodilation in the 
contracting skeletal muscle; (2) differences in the leg blood 
flow response is entirely a function of LVC given that the 
pressor responses were similar between the three groups; (3) 
the small but significant rise in MAP in the subjects with 
type 2 diabetes demonstrates that cardiac function is suffi-
cient to maintain blood pressure in the presence of a progres-
sive decline in leg vascular resistance; and (4) there was no 
difference in the dynamic response of heart rate during calf 
exercise between the three groups. The common interpreta-
tion that a lowered cardiac output or slowed heart rate ‘kinet-
ics’ observed during exercise in type 2 diabetes reflects 
cardiac dysfunction1-4 is, in the absence of simultaneous arte-
rial pressure measurements, tenuous. An alternative expla-
nation for such cardiac responses is that they reflect vascular 
dysfunction and altered responses of limb blood flow.
Relevance to VO2 and exercise tolerance
Like limb blood flow and vascular conductance, V˙o
2
 increases 
in a biphasic manner during moderate exercise. Type 2 dia-
betes slows the second of these two phases of V˙o
2
,3, 6 and we 
have observed the same effect on V˙o
2
 kinetics in a sample of 
women that included many of those who participated in the 
present study.46 Given the close temporal alignment between 
the muscle blood flow and V˙o
2
 responses,47 the present find-
ings suggest that this slowing is, at least in part, due to a 
slowing of the second phase of hyperaemia. Impeding V˙o
2
 
after the onset of exercise exaggerates the fall in muscle PCr 
and pH, increase in P
i
 and loss of force production.48-51 
Therefore, it is likely that the slowing of the hyperaemic 
response (phase 2) contributes directly to the abnormal 
metabolic responses in contracting muscle and the loss of 
exercise tolerance in type 2 diabetes.1-4, 6, 46
Limitations
Although the resting ankle–brachial pressure index is a cri-
terion measure of peripheral arterial disease, it can be inac-
curate in diabetic subjects because of the presence of arterial 
calcification and the associated stiffening. Angiography or 
Doppler ultrasound was not performed in this study and so 
we cannot rule out the presence of clinically significant 
macrovascular disease and its potential influence on the 
slowed hyperaemic response in the diabetic subjects. Both 
pre- and post-menopausal women were studied and meno-
pause appears to reduce endothelial-dependent vasodila-
tion.52 However, this is unlikely to have introduced bias
in the results given that the distribution of pre- and post-
menopausal women was similar in the three groups. The 
accuracy of plethysmographic measurements of leg blood 
flow has been questioned.53,54 However, recent work from 
one of our laboratories shows very close agreement between 
plethysmographic and Doppler ultrasound estimates of leg 
blood flow during calf exercise.55
Conclusion
In conclusion, the present findings demonstrate a slowing of 
the hyperaemic response during calf exercise in type 2 dia-
betes that is attributed to the second phase of this response. 
This lays a foundation for further human research into the 
mechanisms underlying this effect and their impact on meta-
bolic control and exercise tolerance in type 2 diabetes.
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